OrSense NBM-200 Non-Invasive Hemoglobin Device Selected by the Central Blood Bank of Catalonia

PETACH TIKVA, Israel, July 11, 2019 /PRNewswire/ -- OrSense Ltd., a leading developer of systems for non-invasive measurements of hemoglobin, today announces the selection of its NBM-200 non-invasive Hemoglobin measurement device by the Banc de Sang I Teixits, the central blood bank of...

from PR Newswire: https://ift.tt/2Jt2oNQ